130820-52-9Relevant academic research and scientific papers
Trisubstituted and tetrasubstituted pyrazolines as a novel class of cell-growth inhibitors in tumor cells with wild type p53
Abdel-Halim, Mohammad,Keeton, Adam B.,Gurpinar, Evrim,Gary, Bernard D.,Vogel, Simon M.,Engel, Matthias,Piazza, Gary A.,Boeckler, Frank M.,Hartmann, Rolf W.,Abadi, Ashraf H.
, p. 7343 - 7356 (2013)
Derivatives with scaffolds of 1,3,5-tri-substituted pyrazoline and 1,3,4,5-tetra-substituted pyrazoline were synthesized and tested for their inhibitory effects versus the p53+/+ HCT116 and p53-/- H1299 human tumor cell lines. Severa
Design and synthesis of novel 1,3,5-triphenyl pyrazolines as potential anti-inflammatory agents through allosteric inhibition of protein kinase Czeta (PKCζ)
Abdel-Halim, Mohammad,Abadi, Ashraf H.,Engel, Matthias
supporting information, p. 1076 - 1082 (2018/06/27)
Much light has been shed on the vital role of protein kinase Czeta (PKCζ) in NF-κB activation and the potential use of PKCζ inhibitors as anti-inflammatory agents. We previously reported a series of 1,3,5-trisubstituted pyrazolines as potent and selective
Design, synthesis and cytotoxic activity of certain novel chalcone analogous compounds
El-Meligie,Taher, Azza T.,Kamal, Aliaa M.,Youssef
, p. 52 - 60 (2016/10/25)
A series of chalcone analogous compounds were designed and synthesized. Replacing/substituting the enone or ethylenic bridge of the parent chalcone with rigid heterocyclic moieties or substituted aromatic amines gave nineteen target compounds. Their cytot
Effects of structural and electronic characteristics of chalcones on the activation of peroxisome proliferator-activated receptor gamma
Schott, Jason Taylor,Mordaunt, Charles Edward,Vargas, Anthony Joseph,Leon, Martin Antonio,Chen, Kevin Hsinwen,Singh, Mandeep,Satoh, Mikiko,Cardenas, Emilio Leal,Maitra, Santanu,Patel, Nilay Vinod,De Lijser, Hubrecht Johan Peter
, p. 229 - 236 (2013/03/14)
Chalcones share some structural similarities with GW-1929, a highly-selective and potent agonist for peroxisome proliferator-activated receptor-gamma (PPARγ). In this study, we tested 53 structurally diverse chalcones to identify characteristics essential for PPARγ activation in a GAL4-based transactivation assay. This screen identified several novel chalcone agonists of PPARγ. Our results indicate that chalcones with an electron rich group or sterically large groups such as naphthyl on the carbonyl side tend to activate PPARγ. The absence of any strict structural or electronic requirements suggests that the flexibility of the PPARγ ligand binding pocket may allow binding of diverse chalcones with some preference for a slightly larger electron-rich group on the carbonyl side. We predict that further structure-activity relationship studies on chalcones with naphthalene or electron-rich groups near the carbonyl moiety will lead to the development of more potent PPARγ agonists.
